Search for Clinical Trial Results

Sponsored By

Hypophosphatemia, Familial - 22 Studies Found

Status Study
Completed Study Name: Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets
Condition:
  • Hypophosphatemia, Familial
  • Hyperparathyroidism

Date: 2006-12-28
Interventions:
  • Drug: Paricalcitol Paricalcito
Active, not recruiting Study Name: Hypophosphatemic Rickets in Norway
Condition:
  • Hypophosphatemia, Familial
  • Rickets
  • Dietary Supplement: Alfacalcidol; phosphate.

Completed Study Name: Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4
Condition: Chronic Kidney Disease
Date: 2008-10-01
Interventions:
  • Other: grain (soy) protein diet

Recruiting Study Name: Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Date: 2016-05-23
Interventions:
  • Biological: KRN23 KRN23 is a r
Active, not recruiting Study Name: Study of the Safety, Pharmacodynamics and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Date: 2015-12-06
Interventions: Drug: KRN23
Completed Study Name: Growth Hormone Treatment in Children With Hypophosphatemic Rickets
Condition: X Linked Hypophosphatemic Rickets
Date: 2016-03-15
Interventions: Drug: norditropine simplex Other Name: growth hormone
Active, not recruiting Study Name: Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)
Condition: X-linked Hypophosphatemia
Date: 2015-08-25
Interventions: Biological: KRN23 KRN23 is a recombinant human immunoglobulin G isotype 1 (IgG1) monoclonal antibody (mA
Active, not recruiting Study Name: Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)
Condition: X-linked Hypophosphatemia
Date: 2015-07-17
Interventions:
  • Biological: KRN23 KRN23 is a r
Enrolling by invitation Study Name: Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Date: 2014-12-03
Interventions: Drug: KRN23 KRN23 is a recombinant fully human immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that b
Recruiting Study Name: Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.
Condition:
Date: 2023-03-30
Next >>>